Preinfection Prophylaxis with Herpes Simplex Virus Glycoprotein Immunogens: Factors Influencing Efficacy

References

1. Berman P. W., Gregory T., Crase D., Lasky L. A. 1985; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 278:1490–1492
   [Google Scholar]
2. Berman P. W., Vogt P. E., Gregory T., Lasky L. A., Kern E. R. 1988; Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent and latent genital infections with herpes simplex virus type 2 in guinea pigs. Journal of Infectious Diseases 157:897–902
   [Google Scholar]
3. Bernstein D. I., Kappes J. C. 1988; Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide. Archives of Virology 99:57–65
   [Google Scholar]
4. Burke R. L., Pachl C., Quiroga M., Rosenberg S., Haigwood N., Nordfang O., Ezban M. 1986; The functional domains of coagulation factor VIII. Journal of Biological Chemistry 261:12574–12578
   [Google Scholar]
5. Burke R. L., Van Nest G., Carlson J., Gervase B., Goldbeck C., Ng P., Sanchez-Pescador L., Stanberry L. R., Ott G. 1989; Development of a herpes simplex virus subunit vaccine. In Vaccines89 Chanock R. M., Lerner R. A. New York: Cold Spring Harbor Laboratory (in press);
   [Google Scholar]
6. Chan W. L. 1983; Protective immunization of mice with specific HSV-1 glycoproteins. Immunology 49:343–352
   [Google Scholar]
7. Dix R. D. 1987; Prospects for a vaccine against herpes simplex virus types 1 and 2. Progress in Medical Virology 34:89–128
   [Google Scholar]
8. Dix R. D., Mills J. 1985; Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB and gD. Journal of Medical Virology 17:9–18
   [Google Scholar]
9. Long D., Madara T. J., Ponce De Leon M., Cohen G. H., Montgomery P. C., Eisenberg R. J. 1984; Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infection and Immunity 43:761–764
   [Google Scholar]
10. Meignier B., Jourdier T. M., Norrild B., Pereira L., Roizman B. 1987; Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus. Journal of Infectious Diseases 155:921–930
    [Google Scholar]
11. Myers M. G., Bernstein D. I., Harrison C. J., Stanberry L. R. 1988; Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guineas pigs. Antiviral Research 10:83–88
    [Google Scholar]
12. Pachl C., Burke R. L., Sanchez-Pescador L., Van Nest G., Masiars F., Dina D. 1987; Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein B in mammalian cells. Journal of Virology 61:315–325
    [Google Scholar]
13. Phillpots R. J., Welch M. G., Ridgeway P. H., Walkland A. C., Melling J. 1988; A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV-2 genital infection. Journal of Biological Standardization 16:109–118
    [Google Scholar]
14. Prober G. G., Sullender W. M., Yasukawa L. L., Au D. S., Yeager A. S., Arvin A. M. 1988; Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. New England Journal of Medicine 316:240–244
    [Google Scholar]
15. Roberts P. L., Duncan B. E., Raybould T. J. G., Watson D. H. 1985; Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Journal of General Virology 66:1073–1085
    [Google Scholar]
16. Sanchez-Pescador L., Burke R. L., Ott G., Van Nest G. 1988; The effect of adjuvants on the efficacy of a recombinant HSV glycoprotein vaccine. Journal of Immunology 141:1720–1727
    [Google Scholar]
17. Schrier R. D., Pizer L. I., Moorhead J. W. 1983; Type-specific delayed hypersensitivity and protection immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
    [Google Scholar]
18. Stanberry L. R., Kern E. R., Richard J. T., Abbott T. M., Overall J. C. JR 1982; Genital herpes in guinea pigs: Pathogenesis of the primary infection and description of recurrent disease. Journal of Infectious Diseases 146:397–401
    [Google Scholar]
19. Stanberry L. R., Kern E. R., Richard J. T., Overall J. C. JR 1985a; Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology 24:226–231
    [Google Scholar]
20. Stanberry L. R., Kit S., Myers M. G. 1985b; Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. Journal of Virology 55:322–328
    [Google Scholar]
21. Stanberry L. R., Bernstein D. I., Kit S., Myers M. G. 1986; Genital reinfection after recovery from initial genital infection with HSV-2 in guinea pigs. Journal of Infectious Diseases 153:1055–1061
    [Google Scholar]
22. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C., Myers M. G. 1987; Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. Journal of Infectious Diseases 155:914–920
    [Google Scholar]
23. Stanberry L. R., Burke R. L., Myers M. G. 1988; Herpes simplex virus glycoprotein treatment of recurrent genital herpes. Journal of Infectious Diseases 157:156–163
    [Google Scholar]
24. Stephanopoulos D. E., Kappes J. C., Bernstein D. I. 1988; Enhanced in vitro reaction of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine. Journal of General Virology 69:1079–1083
    [Google Scholar]
25. Stuve L. L., Brown-Shimer S., Pachl C., Najarian R., Dina D., Burke R. L. 1987; Structure and expression of herpes simplex type 2 glycoprotein gB gene. Journal of Virology 61:326–335
    [Google Scholar]
26. Thomson T. A., Hilfenhaus J., Moser H., Morahan P. S. 1983; Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice. Infection and Immunity 41:556–562
    [Google Scholar]
27. Yeager A. S., Arvin A. M., Urbani L. J., Kemp J. A. 1980; Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infection and Immunity 29:532–538
    [Google Scholar]